What does catefat do?

Carnitine is an amino acid that is essential for living organisms. Carnitine deficiency can affect health more or less, when patients need to supplement with supportive products. One of the drugs used to supplement carnitine is Catefat 1g. So what does Catefat do?

The main active ingredient of Catefat is Levocarnitine 1g. Carnitine is considered an amino acid, playing an essential role when participating in fat metabolism in cardiac muscle cells, liver cells and skeletal muscle. Carnitine's role is to transport fat into the mitochondria, thereby providing a substrate for oxidation and fat burning to create energy for the body. The active ingredient Levocarnitine in Catefat is used as a supplement for primary carnitine deficiency and secondary carnitine deficiency due to causes such as defects in intermediate metabolism or after certain procedures such as hemodialysis. Both isomers of carnitine L and DL are used in clinical practice, but only the L form (Levocarnitine) is effective and DL - carnitine supplements often lead to carnitine deficiency. .

Some studies have shown that carnitine supplementation may protect heart muscle cells. Cardiomyopathy patients when supplementing with carnitine helps to reduce necrotic areas of the myocardium (in myocardial infarction) and supports increased myocardial mobility in patients with angina or lameness. limping back.
At the same time, a placebo-controlled study in the elderly showed that the addition of Levocarnitine in Catefat 1g significantly reduced mental and physical fatigue. Meanwhile, in people with chronic fatigue syndrome, an improvement in mental fatigue was observed with Acetyl carnitine and general fatigue with Propionylcarnitine. In addition, the active ingredient Levocarnitine is also used to reduce fatigue after cancer chemotherapy or Interferon.

Catefat 1g is indicated in the following cases:
Primary or secondary carnitine deficiency Disorders of myocardial metabolism due to ischemic heart disease such as angina pectoris and myocardial infarction. Reducing mental and physical fatigue in the elderly, people with chronic fatigue syndrome or fatigue caused by cancer chemotherapy drugs, interferon.

Catefat 1g is for oral use only.

Adults can take 2 to 3g of active ingredient Levocarnitine per day, equivalent to 2 to 3 ampoules of Catefat 1g, divided into 2-3 doses.
Dosage of Catefat should be adjusted according to the age, condition and actual symptoms of each specific patient.
The above dosage is for reference only. The specific dose of Catefat depends on the condition and severity of the disease. Therefore, patients should consult their doctor or health professional to receive instructions on the most appropriate dosage.

When you forget to take a dose of Catefat, the patient should use it as soon as he remembers. If it is almost time for your next dose, skip the missed dose and continue taking it at your usual daily schedule.

To date, there have been no reports of poisoning or overdose of Catefat.

During the use of Catefat, patients may experience some undesirable effects (ADRs) as follows:
Digestive dysfunction such as nausea, vomiting, abdominal pain, stomach pain, diarrhea flow ; Body smell; When experiencing abnormal signs when taking Catefat 1g, the patient should stop the drug and promptly notify the doctor or go to the nearest medical facility for timely treatment.

Before using any medicine, including Catefat, patients should carefully read the instructions for use or can refer to the following information. Catefat is contraindicated for use in the following cases:
History of allergy or hypersensitivity to Levocarnitine or any other ingredient in the drug.

Caution when using Catefat 1g:
This product contains Sodium Benzoate, a substance with a high risk of causing irritation to the skin, eyes or mucous membranes; Adding carnitine too quickly can lead to some digestive upsets. Therefore, patients need to drink slowly and divide it into several times a day to increase tolerance; The ability to drive and use machines is not affected by the use of Catefat; Pregnancy: The safety of Catefat products during pregnancy has not been established. Therefore, treatment with Catefat should only be indicated for women who are pregnant or of childbearing potential when weighing the benefits of treatment against the risks to the fetus; Lactation: Use of Levocarnitine in nursing women has not been studied. In this population, the use of Catefat should carefully weigh the risks to the child and the benefits of treatment for the mother. Of note, the possibility of suspending breastfeeding or discontinuing levocarnitine therapy can be considered. Drug Interactions: There have been no reports of drug interactions with Catefat 1g product.